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Table S1. Comparison of baseline characteristics between participants with complete data 
and those lost to follow-up (or with incomplete baseline characteristics) 
Characteristics n Lost to follow-up n Complete 
Age (year) 2462 10.4 (5.0) 1134 10.6 (5.0) 
BMI (kg/m2) 2433 17.8 (3.1) 1134 17.9 (3.1) 
25OHD (nmol/L) 2382 51.0 (15.5) 1134 51.9 (15.3) 
Dietary calcium intake (mg/d) 633 1134 (454) 1134 1142 (462) 
Physical activity index (z score) 2371 0.01 (1.00) 1134 -0.02 (1.00) 
Parental history of diabetes, n (%) 2433 68 (2.8) 1134 20 (1.8) 
Fruit consumption (>6 times/week), n (%) 2429 1941 (80) 1134 914 (81) 
Vegetable consumption (>6 times/week), n (%) 2428 838 (35) 1134 395 (35) 
Smokers, n (%) 2365 154 (6.5) 1134 68 (6.0) 
Parental years of education 2309 10.0 (3.3) 1134 9.8 (3.6) 
Values are mean (standard deviation) unless otherwise stated. 
Abbreviations: BMI, body mass index; 25OHD, 25-hydroxyvitamin D. 
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Table S2. Relative risk and 95% confidence interval for IFG and T2D in adulthood by tertile 
of long-term dietary calcium intake and sex 
  Females  
 Tertile 1 
(n= 193) 
Tertile 2 
(n= 193) 
Tertile 3 
(n= 192) 
Calcium intake, mean (range) 
(mg/d) 
854 (394 to 
1013) 
1149 (1014 to 
1289) 
1553 (1290 to 2462) 
NFG, n (%) a 163 (84) 159 (82) 161 (84) 
IFG, n (%) 27 (14) 26 (14) 23 (12) 
Model 1 Reference 0.99 (0.60 to 1.63) 0.88 (0.52 to 1.48) 
Model 2 Reference 1.06 (0.64 to 1.76) 1.03 (0.62 to 1.71) 
Model 3 Reference 1.09 (0.66 to 1.81) 1.00 (0.60 to 1.67) 
T2D, n (%) 3 (2) 8 (4) 8 (4) 
Model 1 Reference 2.65 (0.71 to 9.83) 2.62 (0.71 to 9.72) 
Model 2 Reference 1.63 (0.38 to 7.11) 2.56 (0.71 to 9.21) 
Model 3 Reference 1.51 (0.37 to 6.11) 2.22 (0.65 to 7.60) 
    
  Males  
 Tertile 1 
(n= 186) 
Tertile 2 
(n= 185) 
Tertile 3 
(n= 185) 
Calcium intake, mean (range) 
(mg/d) 
988 (520 to 
1185) 
1351 (1190 to 
1510) 
1821 (1514 to 3568) 
NFG, n (%) a 131 (70) 121 (65) 109 (59) 
IFG, n (%) 48 (26) 53 (29) 63 (34) 
Model 1 Reference 1.14 (0.82 to 1.58) 1.37 (0.99 to 1.87) 
Model 2 Reference 1.06 (0.77 to 1.47) 1.22 (0.89 to 1.66) 
Model 3 Reference 1.06 (0.77 to 1.47) 1.22 (0.89 to 1.67) 
T2D, n (%) 7 (4) 11 (6) 13 (7) 
Model 1 Reference 1.64 (0.66 to 4.12) 2.10 (0.87 to 5.10) 
Model 2 Reference 1.31 (0.55 to 3.13) 1.30 (0.53 to 3.19) 
Model 3 Reference 1.16 (0.49 to 2.74) 1.35 (0.56 to 2.34) 
Values are relative risk (95% confidence interval) unless otherwise stated. 
a reference group for the outcome comparison. 
Model 1, unadjusted; Model 2, adjusted for age and childhood and adulthood body mass 
index; Model 3, model 2 + baseline serum 25OHD levels, parental history of diabetes, fruit 
and vegetable consumption, physical activity, smoking, and socioeconomic status (parental 
education years). 
Abbreviations: NFG, normal fasting glucose; IFG, impaired fasting glucose; T2D, type 2 
diabetes. 
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Figure S1. Flowchat of participation in the YFS 
 
 
 
 
